| Top
|
| PUBLICATIONS - Miranda Grounds |
| 2013 | |
| 164 pdf | Jackaman C, Radley-Crabb H, Dye HD, Soffe Z, Shavlakadze T, Grounds MD, Nelson DJ. (2013) Targeting macrophages with interleukin-2/CD40 activation rescues age-related functional deficiencies: implications for cancer immunotherapy in the elderly Ageing Cell. Accepted, January 31st |
| 163 pdf | Shavlakadze T, Soffe Z, Anwari T, Cozens G, Grounds MD. (2013) Short-term food deprivation rapidly induces the protein degradation pathway in skeletal muscles of young mice. Journal of Nutrition 143: 1-7. |
| 162 pdf | Terrill J, Radley-Crabb C, Iwasaki T, Peter Arthur, Grounds MD. (2013) (2013) Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. FEBS J. XXX Jan 19. doi: 10.1111/febs.12142. [Epub ahead of print] |
| 161 pdf | Sayer, AA, Patel H, Robinson S, Cooper C, Shavlakadze T, Grounds MD. (2013). New Horizons in the Pathogenesis, Diagnosis and Management of Sarcopenia. Age and Aging doi: 10.1093/ageing/afs191 |
| 2012 |
|
160 |
Terrill J, Radley-Crabb H, Grounds MD, Arthur P. (2012) N-acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis. Neuromuscular Disorders. May;22(5):427-34 |
159 pdf |
Radley-Crabb H, Terrill J, Shavlakadze T, Tonkin J, Arthur P, Grounds M (2012) A single 30 minute treadmill exercise session is suitable for 'proof-of concept studies' in adult mdx mice: a comparison of the early consequences of two different treadmill protocols. Neuromuscular Disorders. Feb;22(2):170-82. Epub 2011 Aug 10 |
158 pdf |
Willmann R, De Luca A, Benatar M, Grounds MD, Dubach J, Raymackers J-M, Nagaraju K: on behalf of the TREAT-NMD Neuromuscular Network (2012). Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice. Neuromuscular Disorders. Jan;22(1):43-49 |
157 |
Newgreen D, Grounds MD, Jesuthasan S, Rashidi H, Familari M. (2012) Report on 2nd Royan Institute International Summer School on Developmental Biology and Stem Cells Tehran, 18-22nd July 2011. Differentiation. 83: 101–105. |
156 |
Prêle CM, Reichelt ME, Mutsaers SE, Davies M, Delbridge LM, Headrick JP, Rosenthal N, Bogoyevitch MA, Grounds MD (2012) Insulin-like growth factor-1 overexpression in cardiomyocytes diminishes ex vivo heart functional recovery after acute ischemia Cardiovascular Pathology 21(1):17-27.
|
| 2011 | |
155 |
Chai RJ, Vukovic J, Dunlop S, Grounds MD, Shavlakadze T (2011) Striking denervation of Neuromuscular Junctions without lumbar motoneuron loss in geriatric mouse muscle. PLoS ONE 6(12): e28090. doi:10.1371/journal.pone.0028090 |
154 |
Crabb HG, Fiorotto ML, Grounds MD. (2011) Different impact of a high fat diet on dystrophic mdx and control C57Bl/10 mice PloS Currents: Muscular Dystrophy November 15; 3: RRN1276. doi: 10.1371/currents.RRN1276 |
153 pdf |
Klyen B, Shavlakadze T, Grounds MD, Hannah G. Radley-Crabb, Sampson D (2011) Identification of muscle necrosis in dystrophic mdx mice using three-dimensional optical coherence tomography. J. Biomedical Optics 16(7), 076013 |
| 152 pdf | El-Shafey AF, Armstrong AE , Terrill JR, Grounds MD, Arthur PG (2011) Screening for increased protein thiol oxidation in oxidatively stressed muscle tissue. Free Radical Research Sep;45(9):991-9. |
151 pdf |
Tohma H, Hepworth A, Shavlakadze T, Grounds MD, Arthur, P. (2011) Quantification of ceroid and lipofuscin in skeletal muscle. J. Histochemistry and Cytochemistry Aug;59(8):769-79. |
150 pdf |
Grounds MD, Shavlakadze T (2011) Growing muscle has different sarcolemmal properties from adult muscle: a proposal with scientific and clinical implications. Bioessays Jun;33(6):458-68. |
149 |
Grounds MD (2011) Regeneration of Muscle (version 2.0) Encyclopedia of Life Science. John Wiley Online: www.els.net Article ID A22172. online August 15 |
| 148 |
Piers AT, Lavin T, Radley-Crabb H, Bakker AJ, Grounds MD, Pinniger GJ. (2011) Blockade of TNF in vivo (using cV1q antibody) reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice. Neuromuscular Disorders Feb;21(2):132-141. |
147 pdf |
McMahon C, Shavlakadze T, Grounds MD. (2011) Role of IGF-I in age-related loss of skeletal muscle mass and function. In Sarcopenia - Age-Related Muscle Wasting and Weakness (Ed. Lynch GS), Springer. pp393-418.
|
2010 |
|
| 146 pdf |
Shavlakadze T, Grounds MD. (2010) IGF-1 is a major regulator of muscle mass during growth but not for adult myofibre hypertrophy. (Comment on Point:counter-point IGF is/is not the major physiological regulator of muscle mass). J of Applied Physiology Jun;108(6):1829. |
145 |
Grounds MD, Relaix F. (2010) Myogenic Precursor Cells in Section I- Scientific basis of muscle disease in 8th Edition of Disorders of Voluntary Muscles (Eds Hilton-Jones D, Griggs RC, Bushby K and Karpati G.) Cambridge University Press. Chapter 2, pp20-36. |
| 144 pdf | Shavlakadze T, Chai R, Maley K, Cozens G, Winn N, Rosenthal N, Grounds G, Grounds M. (2010). A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo. J Cell Science Mar 15;123(Pt 6):960-71. |
|
143 pdf |
Shavlakadze T, McGeachie J, Grounds MD. (2010) Delayed but excellent myogenic stem cell response of regenerating skeletal muscles in geriatric mice. Biogerontology Jun;11(3):363-76. |
| 142 |
Waters F, Shavlakadze T, McIldowie MJ, Piggott MJ, Grounds MD. (2010) Use of pifithrin to inhibit p53 mediated signalling of TNF in dystrophic muscles of mdx mice. Molecular and Cellular Biochemistry 337:119-131.
|
| 2009 | |
| 141 |
Ridgley JA, Pinniger GJ, Hamer P, Grounds MD. (2009) The physiological effects of IGF-1 (Class 1Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic skeletal muscles of mdx mice. Pflugers Archiv –Eur. J Physiol 457(5):1121-32
|
| 2008 | |
| 140 |
Arthur P, Grounds MD, Shavlakadze T. (2008) Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions. Current Opinions in Clinical Nutrition and Metabolic Care 11:408-416 |
| 139 |
Grounds MD, Radley H, Lynch GS, Nagaraju K, De Luca A. (2008) Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne Muscular Dystrophy. Neurobiology of Disease. 31:1-19 |
| 138 |
Grounds MD (2008) Two tiered hypotheses for Duchenne Muscular Dystrophy Visions and Reflections in Cellular and Molecular Life Sciences (CMLS). 65(11):1621-5 |
| 137 |
Smythe G, Shavlakadze T, Roberts P, Davies MJ, McGeachie JK, Grounds MD., (2008) Age influences the early events of skeletal muscle regeneration: studies of whole muscle grafts transplanted between young (2 month) and old (13-21 months) mice. Experimental Gerontology 43: 550-562 |
| 136 |
Klyen BR, Armstrong JJ, Adie SG, Radley HG, Grounds MD, Sampson DD. (2008) Three-dimensional optical coherence tomography of whole muscle autografts as a precursor to morphological assessment of muscular dystrophy in mice. J. Biomedical Optics. Jan-Feb.13(1):011003 |
| 135 |
Grounds MD, Radley H, Gebski B, Bogoyevitch, M, Shavlakadze TS. (2008) Implications of cross-talk between TNFa and IGF-1 signalling in skeletal muscle. Clinical and Experimental Pharmacology and Physiology. 35: 846–851 |
| 134 |
Grounds MD. (2008) Complexity of Extracellular Matrix and Skeletal Muscle Regeneration. In Skeletal Muscle Repair and Regeneration (Ed S Schiaffino and TA Partridge), Springer: Chapter 13. pp269-302. |
| 133 |
Radley H, Davies M, Grounds MD. (2008) Long-term benefits of cV1q (anti-mouse TNF-alpha) antibody treatment in dystrophic mdx mice. Neuromuscular Disorders. 18(3): 227 – 238. |
| 132 |
Schertzer JD, van der Poel C, Shavlakadze T, Grounds MD, Lynch GS. (2008) Muscle specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice. Am J Physiol Cell Physiol. 294:C161–C168 |
| 131 |
Ng DCH, Gebski B, Grounds MD, Bogoyevitch M. (2008) Myoseverin disrupts sarcomeric organization in myocytes: an effect independent of microtubule assembly inhibition. Cell Motility and the Cytoskeleton. 65: 40–58. |
| 130 |
White JD, Vuocolo T, McDonagh M, Grounds MD, Harper G, Cockett NE, Tellam R. (2008) Cellular analysis of the Callipyge phenotype through skeletal muscle development; association of Dlk1 with developing satillite cells. Differentiation. 76:283-298 |
| 2007 | |
| 129 |
Davies KE, Grounds MD (2007) Modified patient stem cells as prelude to autologous treatment of muscular dystrophy Cell Stem Cell 1:595-6 |
|
128 |
Grounds MD, Davies KE. (2007) The allure of stem cell therapy for muscular dystrophy. Neuromuscular Disorders 17(3):206-208. |
|
128b |
Grounds MD. (2007) Book review Tissue Stem Cells (Eds CS Potten, RB Clarke, J Wilson and AG Renehan). Taylor & Francis Group, New York, 2006. 14 Chapters, 389 pages. Australian Biochemist, December http://www.asbmb.org.au/magazine.html |
| 127 |
Radley H, De Luca A, Lynch GS, Grounds MD. (2007) Duchenne Muscular Dystrophy: focus on pharmaceutical and nutritional interventions. International Journal of Biochemistry and Cell Biology. 39(3):469-77. |
| 2006 |
|
| 126 |
Davies KE, Grounds MD (2006) Treating muscular dystrophy with stem cells? Cell. 127 (7):1304-6. |
| 125 |
Shavlakadze T, Grounds MD.(2006) Of bears, meat, mice and men: complexity of factors affecting skeletal muscle mass and fat. BioEssays 28(10): 994-1009. |
| 124 |
Hodgetts, S, Radley, H, Davies M, Grounds MD. (2006) Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFa function with Etanercept in mdx mice. Neuromuscular Disorders 16 591-602. |
| 123 |
Han R, Grounds MD, Bakker AJ. (2006) Measurement of sub-membrane [Ca2+] in adult myofibers and cytosolic [Ca2+] in myotubes from normal and mdx mice using the Ca2+ indicator FFP-18. Cell Calcium 40(2006) 299-307. |
| 122 |
Radley H, Grounds MD. (2006) Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice. Neurobiology of Disease 23(2006) 387-397. |
| 121 |
Shavlakadze T, White JD, Davies M, Grounds MD, Boswell JM, Burt DW, Asante EA, Tomas FM, Goddard C. (2006) Rsk?-actin/hIGF-I transgenic mice with increased IGF-I levels in skeletal muscle and blood: impact on regeneration, denervation, atrophy and muscular dystrophy. Growth Hormone and IGF Research Jun;16(3):157-73. |
| 2005 | |
| 120
|
Pullen T and Grounds MD. (2005) Muscle derived stem cells: Implications for effective Myoblast Transfer Therapy (International Union of Biochemistry and Molecular Biology) IUBMB Life. 57(11):731-736 |
| 119 |
Grounds MD, Catts, Zurr. (2005) Making strange or making sense – Art and the Life Sciences. Australian Life Scientist. March/April 2:2. p14. |
| 118 |
Pullen TP & Grounds MD (2005) The reality of skeletal muscle stem cells. Australian Biochemist April. 26(1): 4-6 (Guest editor for 4 other articles and editorial). |
| 117 |
Grounds MD (2005) The wonder of stem cells and their clinical applications. Australian Biochemist. Editorial (Guest editor for 4 articles). Stem Cells. April. 26(1): p3 |
| 116 |
Grounds MD, Sorokin L, White J. (2005) Strength at the extracellular-muscle interface. Scandinavian Journal of Medicine & Science in Sports 15, 381-391. |
| 115 |
Grounds MD, Davies M, Torrisi J, Shavlakadze J, Hodgetts S. (2005) Silencing TNFa activity using Remicade® or Enbrel® blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice. Cell and Tissue Research. 320(3):509-15. |
| 114 |
Lynch G, Shavlakadze T, Grounds M.D. (2005) Strategies to reduce age-related skeletal muscle wasting. In: Ageing Interventions and Therapies (Ed, Rattan SIS) World Scientific Publishers, Singapore. Chapter 4. pp 63-84. |
|
113
|
Shavlakadze T, White J, Davies M, Hoh JYF, Grounds MD (2005) Insulin-like growth factor-1 slows the rate of denervation induced skeletal muscle atrophy. Neuromuscular Disorders. 15: 139-146. |
| 112 |
Shavlakadze T, Rosenthal NA, Wynn N, Grounds MD Reconciling data from transgenic mice that over-express IGF-1 specifically in skeletal muscle. Growth Hormone and IGF Research 15: 4-18. |
| 2004 | |
| 111 |
Bosio E, Lee-Pullen TF, Fragall CT, Beilharz MW; Bennett AL; Grounds MD, Hodgetts SI, Sammels LM (2004) A Comparison Between Real-Time Quantitative PCR and DNA Hybridization for Quantitation of Male DNA Following Myoblast Transplantation. Cell Transplantation, 2004, 13(7-8), pp. 817-821. |
| 110 |
Grounds MD (2004). Discussion: Reconstruction of ablated rat rectus abdominis by muscle regeneration plastic and reconstructive surgery. 114(6):1516-1518 |
| 109 |
Shavlakadze T, White J, Rosenthal NA, Grounds MD (2004) Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice. Molecular Therapy. Nov;10(5):829-43. |
| 108 |
Shavlakadze T, White JD, Davies M, Grounds MD (2004) Early regeneration of whole skeletal muscle grafts is unaffected by over-expression of IGF-1 in MLC/mIGF-1 transgenic mice. J. Histochem Cytochem 52(7):873-883 |
| 107 |
Lee-Pullen TF, Bennett A, Beilharz MW, Grounds MD, Sammels LM. (2004) Superior survival and proliferation following transplantation of myoblasts obtained from adult mice compared to neonatal mice. Transplantation. Oct 27;78(8):1172-6. |
| 106 |
Sammels L, Bosio E, Fragall CT, Grounds MD, van Rooijen N, Beilharz MW. (2004). Innate inflammatory cells are not responsible for early death of donor myoblasts following Myoblast Transfer Therapy. Transplantation. 27;77 (12): 1790-1797. |
| 105 |
Lloyd CM, Berendse M, Lloyd DG, Schevzov G and Grounds MD. (2004) A novel role for non-muscle y-actin in skeletal muscle sarcomere assembly. Experimental Cell Research. 297:82-96 |
| 104 |
Grounds MD and Torrisi J. (2004) Anti-TNFa (Remicade®) therapy protects dystrophic skeletal muscle from necrosis. FASEB J. 18: 676-682. |
| 2003 | |
| 103 |
Berendse M, Grounds MD and Lloyd CM (2003). Myoblast structure affects subsequent skeletal myotube morphology and sarcomere assembly. Exp. Cell Res. 291: 435-50. [available online through ECR www site]. |
| 102 |
Hodgetts SI and Grounds MD (2003). Irradiation of dystrophic host tissue prior to Myoblast Transfer Therapy enhances initial (but not long-term) survival of donor myoblasts. J. Cell Science Oct 15;116(Pt 20):4131-4146. |
| 101 |
Han R, Suizu T, Grounds M and Bakker AJ. Effect of indomethacin on force responses and sarcoplasmic reticulum function in skinned skeletal muscle fibres and cytosolic [Ca2+] in myotubes. American Journal of Physiology Cell Physiology. Oct:285(4): C881-C890. Epub 2003 June 18. |
| 100 |
Shavlakadze T and Grounds M (2003). Therapeutic interventions for age-related muscle wasting: importance of innervation and exercise for preventing sarcopenia. Chapter in 'Modulating aging and longevity'. Series on Biology of Ageing and its modulation (5 volume series), Kluwer Academic Publisher, the Netherlands. Series Editor: Professor Suresh Rattan, University of Aarhus, Denmark). Volume 5: Chapter 9, pp 139-166. |
| 99 |
White J and Grounds M (2003). Harnessing the therapeutic potential of myogenic stem cells. (Invited review). Cytotechnology 41: 153-164. |
|
98 |
Hodgetts S and Grounds MD (2003). A role for Natural Killer cells in the rapid death of cultured donor myoblasts after transplantation. Transplantation 75(6): 863-871. |
| 2002 | |
| 97 |
White Jason D, Davies Marilyn, McGeachie John and Grounds Miranda D (2002). An evaluation of Leukaemia Inhibitory Factor as a potential therapeutic agent for the treatment of muscle disease. Neuromuscular Disorders. 12(10): 909-916. |
| 96a |
Grounds M (2002). The potential of stem cells for repair of skeletal and cardiac muscle. Proceedings from "Cloning, stem cell research and transgenics" (seminar organised by Western Australian Reproductive Technology Council on May 24th, 2002, Perth) pp 17-21. |
| 96 |
Smythe GM, Lai M-C, Rakoczy P and Grounds MD. Adeno-associated virus-mediated transfer of vascular endothelial growth factor in skeletal muscle prior to transplantation, promotes revascularisation of the regenerating skeletal muscle. Tissue Engineering. 8(5): 879-891. |
| 95 |
Grounds MD, White J, Rosenthal N and Bogoyevitch M (2002). The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 50: 589-610. |
| 94 |
White JD, Collins R, Vermeulen R, Davies M and Grounds MD (2002). The role of p53 in vivo during skeletal muscle post-natal development and regeneration: studies in p53 knockout mice. International J. Develop. Biol. 46: 577-582. |
| 93 |
Hamer PW, McGeachie JM, Davies MJ and Grounds MD (2002). Evans Blue Dye as an in vivo marker of myofibre fragility and damage: Optomising parameters for detecting initial myofibre permeability. J. Anatomy. 200(1) 69-79. |
| 92 |
Grounds MD (2002). Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology. 3(1-2): 19-24 |
| 2001 | |
| 91 |
White JD, Davies M and Grounds MD. Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vitro and in vivo studies in post-natal skeletal muscle. Cell Tissue Res. 306:129-141. |
| 90 |
Smythe G and Grounds MD (2001). Absence of MyoD increases donor myoblast migration into host muscle. Experimental Cell Research. 267:267-274. |
| 89 |
Huijbregets J, White JD and Grounds MD. The absence of MyoD in regenerating skeletal muscle affects the expression pattern of basement membrane, interstitial matrix and integrin molecules that is consistent with delayed myotube. Acta Histochemica 103(4):379-96. |
|
88 |
Collins RA and Grounds MD (2001). The role of Tumour Necrosis Factor-alpha (TNFa) in muscle regeneration: Studies in TNFa(-/-) and TNFa(-/-) /LTa(-/-) mice. J. Histochem. Cytochem. 49:989-1001. |
| 87 |
Smythe G Hodgetts S and Grounds MD (2001). Problems and solutions in myoblast transfer therapy. Invited review. J. Cellular and Molecular Medicine. 5(1):33-47. |
| 86 |
Smythe G, Davies M, Paulin D and Grounds M (2001). Absence of desmin slightly prolongs myoblast differentiation and delays fusion in vivo in regenerating grafts of skeletal muscle. Cell & Tissue Research 304:287-294. |
| 85 |
Hodgetts SI and Grounds MD (2001). Complement and myoblast transfer therapy: Donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5. Immunology and Cell Biology. 79 (3): 231-239. |
| 2000 | |
| 84b |
Grounds MD (2000). Muscling in on Tissue Engineering. Today's Life Science 12(6): 36-40. |
| 84 |
White J, Scaffidi A, McGeachie JM, Davies M, Rudnicki M and Grounds MD (2000). Myotube formation is delayed but not prevented in MyoD deficient skeletal muscle: studies in regenerating whole muscle grafts of adult mice. J. Histochem. Cytochem. 48(11): 1531-1544. |
| 83 |
Grounds MD (2000). Myoblast transfer therapy in the new Millenium: Commentary. Cell Transplantation. 9(4): 485-487. |
| 82 |
Hodgetts SI, Beilharz MW, Scalzo AA and Grounds MD (2000). Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ or NK1.1+ cells. Cell Transplantation. 9(4): 489-502. |
| 81 |
Sorokin LM, Maley MAL, Moch H, von der Mark H, Cadalbert, Karosi S, Davies MJ, McGeachie JK and Grounds MD (2000). Laminin 4 and integrin 6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injury. Experimental Cell Research. 256: 500-514. |
|
80 |
Smythe GM, Hodgetts SI and Grounds MD (2000). Immunobiology and the future of Myoblast Transfer Therapy. Molecular Therapy. 1(4);304-313. |
|
79 |
Smythe GM and Grounds MD (2000). Exposure to tissue culture conditions can adversely affect myoblast behaviour in vivo in whole muscle grafts: implications for myoblast transfer therapy. Cell Transplantation. 9(3): 379-393. |
| 78 |
Smythe G, Fan Y and Grounds MD. Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle. Muscle & Nerve 23(4):560-574. |
| 1999 | |
| 77b |
Hodgetts S. and Grounds M.D. (1999). Isolation of mouse skeletal myoblasts with Blendzyme 3. |
| 77a |
Grounds M.D. (1999). Muscle Repair and Gene Therapy. In Genetics: facts, fiction, issues and ethics. A Ghisalberti, B. Durston and D. Moore. Perth, WA. 1998 Lecture Series. Scitech, Hereditary Disease Program, & Human Genetics Society of Australasia. 91-104, & 129-135. |
| 77 |
Grounds M.D. (1999). Muscle Regeneration: molecular aspects and therapeutic implications. Current Opinion in Neurology. 12: 535-543. |
| 76 |
McGeachie J.K. and Grounds M.D. (1999). The timing between myoblast replication and fusion into myotubes, and the stability of regenerated myofibres in dystrophic muscle: an autoradiographic study in mdx mice. J. Anatomy 194(2): 268-295. |
| 75 |
Ringelmann B., Roder C., Hallmann R., Maley M., Davies M., Grounds M.D. and Sorokin L.M. (1999). Expression of laminin 1, 2, 4 and 5 chains, fibronectin and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Exp. Cell Res. 246: 165-182. |
| 1998 | |
| 74 |
Grounds M.D. (1998). Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. In Towards Prolongation of the Healthy Life Span: Practical Approaches to Intervention Ann. N.Y. Acad. Sci. 854:78-91. |
| 73 |
Grounds M.D. and McGeachie J.K. (1999). 'Therapeutic uses of muscle and factors controlling the efficiency of whole muscle graft regeneration'. In: "Composite Tissue Transplantation" (Charles E Hewitt & Dr Kirby Black, Eds), Tissue Engineering Intelligence Unit Series, RG Landes Bioscience Co, Texas, USA. Chapter 11, pp121-137. |
| 72 |
Grounds M.D., McGeachie J.K., Davies M.V., Sorokin L.M. and Maley M.A.L. (1998). The expression of extracellular matrix during adult skeletal muscle regeneration: how the basement membrane, interstitium and myogenic cells collaborate. Basic & Applied Myology 8(2): 129-141. |
| 1997 | . |
| 71 |
Davies M.J., Mitchell C.A., Maley M.A.L., Grounds M.D., Harvey A.R., Plant G.W., Wood D.J., Hong Y. and Chirila T.V. (1997). In vitro asessment of the biological activity of basic fibroblast growth factor released from various polymers and biomatrices. J Biomaterials Applications. 12:31-56. |
|
70 |
Roberts P., McGeachie J.K. and Grounds M.D. (1997). The host environment determines strain-specific differences in the timing of skeletal muscle regeneration: cross-transplantation studies between SJL/J and BALB/c mice. J. Anatomy. 191:585-594. |
| 69c |
Dodson D., Yablonka-Reuveni Z., Bandmann E. and Grounds M. (1997). Basic & Applied Myology: a reflection of our roots and vision for the immediate future. Basic & Applied Myology. 7(3/4): 295-298. |
| 69b |
Grounds M.D. (1997). Editorial: Satellite cells and Myoblast Transfer Therapy. Basic & Applied Myology. 7(3/4): 160. |
| 69 |
Fan Y., Grounds M.D., Garlepp M. and Beilharz M.W. (1997). Increased survival, movement and fusion of myoblasts from sliced muscle grafts into skeletal muscle of T-cell depleted and tolerised host mice. Basic & Applied Myology. 7(3/4): 231-240. |
| 68 |
Pimorady-Esfahani A., Grounds M.D. and McMenamin P.G. (1997). Macrophages and dendritic cells in normal and regenerating murine skeletal muscle. Muscle & Nerve. 20(2): 158-166. |
| 67b |
Partridge T., Beauchamp J., Morgan J., Tremblay J.P., Huard J., Watt D., Wernig A., Irintchev A., Grounds M., Springer M.L., Bartlett R., Mendell J., Vilquin J-T. and Bower J. Letter to the Editor. (1997) Cell Transplantation 6(2):195-196 |
| 1996 | |
| 67a |
Grounds M.D. (1997). Honk if you are Leonardo - Reconnecting Art and Anatomy. Catalogue contribution for Art, Medicine and the Body. Exhibition held August/September at the Perth Institute of Contemporary Arts. |
| 67 |
Grounds M.D. and Davies MJ (1996). Chemotaxis in myogenesis. Basic & Applied Myology 6(6): 469-483. |
| 66 |
Fan Y., Maley M.A., Beilharz M.W. and Grounds M.D. (1996). Rapid death of donor myoblasts after intramuscular injection in myoblast transfer therapy. Muscle & Nerve.19; 853-860. |
| 65 |
Grounds M.D. (1996). Commentary on the present state of knowledge for myoblast transfer therapy. Cell Transplantation. 5(3):431-433. |
| 64 |
Fan Y., Beilharz M.W. and Grounds M.D. (1996). A potential alternative strategy for Myoblast Transfer Therapy : the use of sliced muscle grafts. Cell Transplantation. 5(3): 421-429. |
| 63 |
Mitchell C.M., McGeachie J.M. and Grounds M.D. (1996). The exogenous administration of basic fibroblast growth factor to regenerating skeletal muscle in mice does not enhance the process of regeneration. Growth Factors 13: 1-19. |
| 62 |
Mitchell C.A., Davies M.J., McGeachie J.K., Grounds M.D., Crawford G.C., Hong Y. and Chirila T.V. (1996). Enhancement of neovascularization in regenerating skeletal muscle by the sustained release of eurucamide from a polymer matrix. J. Biomaterials Applications. 10:230-249. |
| 1995 | |
| 61 |
Maley M.A.L., Davies M.J. and Grounds M.D. (1995). Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle. Exp. Cell Res. 219: 169-179. |
| 60 |
Mitchell C.M., Papadimitriou J.M. and Grounds M.D. (1995). The genotype of bone-marrow derived inflammatory cells does not account for differences in skeletal muscle regeneration between SJL/J and BALB/c mice. Cell Tiss.Res. 208:407-413. |
| 59 |
McGeachie J.K. and Grounds M.D. (1995). Retarded myogenic cell replication in regenerating skeletal muscle of old mice : an autoradiographic study in young and old BALB/c and SJL/J mice. Cell Tiss. Res. 280: 277-282. |
| 58 |
Anderson J.E., Mitchell C.M., McGeachie J.K. and Grounds M.D. (1995). The time course of Basic Fibroblast Growth Factor expression in crush-injured skeletal muscles of SJL/J and BALB/c mice. Exp. Cell Res. 216: 325-334. |
| 1994 | |
| 57 |
Maley M.A.L., Fan Y., Beilharz M.W. and Grounds M.D. (1994). Intrinsic differences in MyoD and myogenin expression between primary cultures of skeletal muscle cells from adult SJL/J and BALB/c mice. Exp. Cell Res. 222(1):99-107. |
| 1993 | |
| 56 |
Grounds M.D. and Yablonka-Reuveni Z. (1993). Invited chapter on "Molecular and cell biology of skeletal muscle regeneration.," In: Molecular and Cell Biology of Muscular Dystrophy (Ed. Partridge TA), Chapman and Hall. Chap 9, p210-256. |
| 55 |
Harvey A.R., Fan Y., Connor A.M., Grounds M.D. and Beilharz M.W. (1993). The migration and intermixing of donor and host glia on nitrocellulose polymers implanted into cortical lesion cavities in mice and rats. Invited paper. Int. J. Dev. Neuroscience 11(5):569-581. |
| 54 |
Fletcher S., Darragh D., Fan Y., Grounds M.D., Fisher C.J. and Beilharz M.W. (1993). Specific cloning of DNA fragments unique to the dog Y-chromosome. Gene. Analy. Techn. Appl. 10(3-4):p77-83. |
| 53 |
McGeachie J.K., Grounds M.D., Partridge T.A. and Morgan J.E. (1993). Age-related changes in replication of myogenic cells in mdx mice : quantitative autoradiographic studies. J. Neurol. Sci. 119: 169-179. |
| 52 |
Anderson J.E., Kakulas B.A., Jacobsen P.F., Johnsen R.D., Kornegay J.N. and Grounds M.D. (1993). Comparison of basic Fibroblast Growth factor levels in X-linked dystrophin-deficient myopathies of human, dog and mouse. Growth Factors. 9(2): 107-121. |
| 51 |
Robertson T.A., Papadimitriou J.M. and Grounds M.D. (1993). Fusion of myogenic cells to the newly sealed region of damaged myofibres in skeletal muscle regeneration. Neuropath. Appl. Neurobiol. 19:350-358. |
| 50 |
Robertson T.A., Maley M.A.L., Grounds M.D. and Papadimitriou J.M. (1993). The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp. Cell Res. 207: 321-331. |
| 49 |
Lynch D.M., Kay P.H., Papadimitriou J.M. and Grounds M.D. (1993). Studies on the structure of complement C3 and the stability of C3 derived phagocytic ligands C3b/iC3b in SJL/J and BALB/c mice. Eur. J. Immunogen. 20: 1-9. |
| 1992 | |
| 48 |
McGeachie J.K., Grounds M.D., Partridge T.A. and Morgan J.E. (1992). Replication of myogenic cells with age, and myogenesis after experimental injury in mdx mouse muscle: Quantitative autoradiographic studies. In: "Duchenne Muscular Dystrophy : Animal Models and Genetic Manipulation" (Eds. BA Kakulas, J McHowell, and A Roses) Raven Press, New York. Chapter 16, p189-201. |
| 47 |
Beilharz M.W., Garrett K.L., Fan Y., Fletcher S., Lareu R., Maley M., Vague M., Harvey A.R. and Grounds M.D. (1992). Genetic probes for tracking muscle precursor cells in vivo: technical aspects. In: "Duchenne Muscular Dystrophy : Animal Models and Genetic Manipulation" (Eds. BA Kakulas, J McHowell, and A Roses) Raven Press, New York. Chapter 14, p165-174. |
| 46 |
Robertson T.A., Grounds M.D. and Papadimitriou J.M. (1992). Fusion of myogenic cells in vivo. In: "Duchenne Muscular Dystrophy : Animal Models and Genetic Manipulation" (Eds. BA Kakulas, J.McHowell, and A. Roses) Raven Press, New York. Chapter 13, p155-164. |
| 45 |
Grounds M.D., Robertson T.A., Mitchell C.A. and Papadimitriou J.M. (1992). Necrosis and regeneration in dystrophic and normal skeletal muscle. In: "Duchenne Muscular Dystrophy : Animal Models and Genetic Manipulation" (Eds. BA Kakulas, J. McHowell, and A. Roses) Raven Press, New York. Chapter 12, p141-153. |
| 44 |
Garrett K.L., Grounds M.D., Maley M.A.L. and Beilharz M.W. (1992). Interferon inhibits myogenesis in vitro and in vivo. Basic & Applied Myology 2(4):291-298 |
| 43 |
Robertson T.A., Grounds M.D. and Papadimitriou J.M. (1992). Elucidation of aspects of murine skeletal muscle regeneration using local and whole body irradiation. J. Anat. 181(2):265-276. |
| 42 |
Garrett K.L., Grounds M.D. and Beilharz M.W. (1992). Non-specific binding of nucleic acid probes to paneth cells in the gastrointestinal tract using in situ hybridization. J. Histochem. Cytochem. I40(10):1613-1618. |
| 41 |
Beilharz M.W., Lareu R.R., Garrett K.L., Grounds M.D. and Fletcher S. (1992). Quantitation of muscle precursor cell activity in skeletal muscle by Northern analysis of MyoD and myogenin expression: Application to dystrophic (mdx) mouse muscle. Mol. Cell. Neuroscience 3(4):326-333. |
| 40 |
Mitchell C.A., McGeachie J.K. and Grounds M.D. (1992). Cellular differences in the regeneration of murine muscle. A quantitative histological study in SJL/J and BALBc mice. Cell Tiss. Res. 269 (1):159-166. |
| 39 |
McGeachie J.K., Smith E., Roberts P. and Grounds M. (1992). The reaction of skeletal muscle to small implants of titanium and stainless steel: a quantitative histological and autoradiographic study. Biomaterials 13:562-568. |
| 38 |
Robertson T.A., Papadimitriou J.M. and Grounds M.D. (1992). Fusion between a myogenic cell located in "the satellite cell" position and undamaged muscle fibre segments. Experientia 48:(4):394-395. |
| 37 |
Grounds M.D. and McGeachie J.K. (1992). Skeletal muscle regeneration after crush injury in dystrophic mdx mice: an autoradiographic study. Muscle & Nerve. 15:580-586. |
| 36 |
Harvey A.R., Fan Y., Beilharz M.W. and Grounds M.D. (1992). Survival and migration of transplanted male glia in adult female mouse brains, monitored by a Y-chromosome-specific probe. Mol. Brain Res. 12:339-343. |
| 35 |
Grounds M.D., Garrett K.L. and Beilharz M.W. (1992). The transcription of MyoD1 and myogenin genes in thymic cells in vivo. Exp. Cell Res. 198:357-361. |
| 34 |
Grounds M.D., Garrett K.L., Lai M.C., Wright W.E. and Beilharz M.W. (1992). Identification of muscle precursor cells in vivo by use of MyoD1 and myogenin probes. Cell Tiss. Res. 267:99-104. |
| 1991 | |
| 33 |
Beilharz M.W., Garrett K.L., Fan Y., Harvey A.R., May C.L., Codling J.C. and Grounds M.D. (1991). Use of the Y-chromosome as a cell marker in transplantation studies. Proc. Aust. Physiol. Pharmacol. Soc. 22(2):168-177. |
| 32 |
Mitchell C.A., Grounds M.D. and McGeachie J.K. (1991). The effect of low dose Dexamethasone on skeletal muscle regeneration in vivo. Basic & Applied Myology 1(2):139-144. |
| 31 |
Grounds M.D., Lai M.C., Fan Y., Codling J.C. and Beilharz M.W. (1991). Transplantation in the mouse model : the use of a Y-chromosome specific DNA clone to identify donor cells in situ. Transplantation 52(6): 1101-1105. |
| 30 |
Grounds M.D. (1991). Invited review - Towards understanding skeletal muscle regeneration. Pathology Res. & Pract. 118: 1-22. |
| 1990 | |
| 29 |
Grounds M.D. (1990). Peptide growth factors in myogenesis and regeneration. In: "Muscle and Motility" (Eds. Marechal G and Carraro U). Intercept Ltd., U.K., Chapter 6, pp 39-43. |
| 28 |
Grounds M.D. (1990). The proliferation and fusion of myoblasts in vivo. In "Myoblast Transfer Therapy" (Eds. Eastwood A.B., Karpati G. and Griggs R.). Proceedings of the 1st International Conference on myoblast transfer therapy held in New York City, June 10-11, 1989. Plenum Press pp 101-106. |
| 27 |
McGeachie J.K. and Grounds M.D. (1990). Applications of an autoradiographic model of myogenesis in vivo. In "Pathogenesis and Therapy of Duchenne and Becker Muscular Dystrophy." (Eds. Kakulas B.A. and Mastaglia F.L.). Raven Press, New York, pp 151-170. |
| 26 |
Grounds M.D. (1990). Factors controlling skeletal muscle regeneration in vivo. In: Pathogenesis and Therapy of Duchenne and Becker Muscular Dystrophy". (Eds. Kakulas B.A. and Mastaglia F.L.). Raven Press, New York, pp 171-185. |
| 25 |
Robertson T.A., Papadimitriou J.M., Mitchell C.A. and Grounds M.D. (1990). Fusion of myogenic cells in vivo : an ultrastructural study of regenerating murine skeletal muscle. J. Struct. Biol.. 105: 170-182. |
| 24 |
Papadimitriou J.M., Robertson T.A., Mitchell .CA. adn Grounds M.D. (1990). The process of new plasmalemma formation in focally injured skeletal muscle fibres. J. Struct. Biol. 103:(2) 124-134. |
| 23 |
Grounds M.D. and McGeachie J.K. (1990). Myogenic cell replication in minced skeletal muscle isografts of Swiss and BALBc mice. Muscle & Nerve 123: 305-313. |
| 1989 | |
| 22 |
Morlet K., Grounds M.D. and McGeachie J.K. (1989). Muscle precursor replication after repeated regeneration of skeletal muscle. Anat. Embryol. 180 (5): 471-478 |
| 21 |
Roberts P., McGeachie J.K., Smith E.R. and Grounds M.D. (1989). The initiation and duration of myogenesis in transplants of intact skeletal muscles: an autoradiographic study in mice. Anat. Rec. 224: 1-6. |
| 20 |
McGeachie J.K. and Grounds M.D. (1989). The onset of myogenesis in denervated mouse skeletal muscle regenerating after injury. Neuroscience. 28(2): 509-514. |
| 19 |
Grounds M.D. and McGeachie J.K. (1989). Myogenic cells of regenerating adult chicken muscle can fuse into myotubes after a single cell division in vivo. Exp. Cell Res. 180: 429-439. See comment for paper #17. |
| 18 |
Grounds M.D. and McGeachie J.K. (1989). A comparison of muscle precursor replication in crush injured skeletal muscle of Swiss and BALBc mice. Cell Tiss Res. 255, 385-391 |
| 1987 | |
| 17 |
Grounds M.D. and McGeachie J.K. (1987). A model of myogenesis in vivo, derived from detailed autoradiographic studies of regenerating skeletal muscle, challenges the concept of quantal mitosis. Cell Tiss Res. 250: 563-569. |
| 16 |
Grounds M.D. and McGeachie J.K. (1987). Reutilisation of tritiated thymidine in studies of regenerating skeletal muscle. Cell Tiss. Res. 250: 141-148. |
| 15 |
McGeachie J.K. and Grounds M.D. (1987). Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle. Cell Tiss. Res. 248: 125-130. |
| 14 |
Grounds M.D. (1987). Phagocytosis of necrotic muscle in muscle isografts is influenced by the strain, age and sex of host mice. J. Pathol. 153: 71-82. |
| 1986 | |
| 13 |
Grounds M.D. (1986). The development of fibre types in grafts of a slow tonic avian muscle the dorsocutaneous latissimus dorsi. Cell Differ. 19: 207-224. |
| 12 |
McGeachie J.K. and Grounds M.D. (1986). Cell proliferation in denervated skeletal muscle. Does it provide a pool of potential circulating myoblasts? Bibl. Anat. 29: 173-193. |
| 1985 | |
| 11 |
McGeachie J.K. and Grounds M.D. (1985). Can cells extruded from denervated muscle become circulating potential myoblasts? Implications of 3H-thymidine reutilisation in regenerating muscle. Cell Tiss. Res. 242: 25-32. |
| 1984 | |
| 10 |
Murch A.R., Grounds M.D. and Papadimitriou J.M. (1984). Improved chimaeric mouse model confirms that resident peritoneal macrophages are derived solely from bone marrow precursors. J. Pathol. 144: 81-87. |
| 1983 | |
| 9 |
Grounds M.D. (1983). Skeletal muscle precursors do not arise from bone marrow cells. Cell. Tiss. Res. 234: 713-722. |
| 8 |
Grounds M.D. and Partridge T.A. (1983). Isoenzyme studies of whole muscle grafts and movement of muscle precursor cells. Cell Tiss. Res. 230: 677-688. |
1982 |
|
| 7 |
Murch A.R., Grounds M.D., Marshall C.A. and Papadimitriou J.M. (1982). Direct evidence that inflammatory multinucleate giant cells form by fusion. J. Pathol. 137: 177-180. |
| 1981 | |
| 6 |
Grounds M.D. (1981). X-linked gene loci and muscular dystrophy. Aust. J. Exp. Biol. Med. 59: 617-622. |
| 1980 | |
| 5 |
Grounds M.D. (1980). Effect of dithiothreitol on kinetics of mammalian and non-mammalian phosphoglycerate kinase. Comp. Biochem. Physiol. 67B: 599-603 |
| 4 |
Grounds M.D., Partridge T.A. and Sloper J.C. (1980). The contribution of exogenous cells to regeneration of skeletal muscle: an isoenzyme study of muscle allografts in mice. J. Pathol. 132: 325-341. |
| 1978 | |
| 3 | Grounds M.D. (1978). The contribution of host and donor cells to regenerating skeletal muscle grafts in mice: investigations using glucose-6-phosphate isomerase isoenzyme markers. PhD Thesis, University of London. |
| 2 |
Partridge T.A., Grounds M.D. and Sloper J.C. (1978). Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 273: 306-308. |
| 1976 | |
| 1 | Trinick M.J., Dilworth M.J. and Grounds M.D. (1976). Factors affecting the reduction of acetylene by root nodules of the Lupinus species. New Phytol 77: 359-370. |
Updated: 1100 10th January 2007
